Lataa...
The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies
BACKGROUND: A previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16 wk. of treatment, and over 4 wk. of...
Tallennettuna:
| Julkaisussa: | BMC Vet Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6390376/ https://ncbi.nlm.nih.gov/pubmed/30808423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-019-1811-2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|